Antibodies to GD1α and to GQ1β in Guillain-Barre syndrome and the related disorders

Journal of the Neurological Sciences

Volumn 165, Issue 2, 1999, Pages 126-132

  Odaka, Masaaki ^a   Yuki, Nobuhiro ^a   Yoshino, Hiide ^b   Kiso, Makoto ^c   Ishida, Hideharu ^c   Hirata, Koichi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b National Center for Global Health and Medicine   (Japan)

^c GIFU UNIVERSITY   (Japan)

Author keywords

Anti ganglioside antibody; Fisher's syndrome; GD1 ; GQ1 ; Guillain Barre syndrome

Indexed keywords

AUTOANTIBODY; GANGLIOSIDE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1A; GANGLIOSIDE GQ 1B; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GANGLIOSIDE GD1ALPHA; GANGLIOSIDE GM1; GQ1B GANGLIOSIDE; NERVE GROWTH FACTOR;

ARTICLE; CATTLE; GUILLAIN BARRE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SUBCLAVIAN STEAL SYNDROME; ANTIBODY SPECIFICITY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOCHEMISTRY; IMMUNOLOGY; METABOLISM; OCULOMOTOR NERVE; PERIPHERAL NERVE; POLYRADICULONEUROPATHY; THIN LAYER CHROMATOGRAPHY;

ANTIBODY SPECIFICITY; AUTOANTIBODIES; CHROMATOGRAPHY, THIN LAYER; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; G(M1) GANGLIOSIDE; GANGLIOSIDES; IMMUNOCHEMISTRY; NERVE GROWTH FACTORS; OCULOMOTOR NERVE; PERIPHERAL NERVES; POLYRADICULONEUROPATHY;

EID: 0033137305     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00097-0     Document Type: Article

References (33)

1. Hakomori S. Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Annu Rev Biochem. 50:1981;733-764.
2. Ando S. Gangliosides in the nervous system. Neurochem Int. 5:1983;507-537.
3. Visser L.H., van der Meché F.G.A., van Doorn P.A., Meulstee J., Jacobs B.C., Oomes P.G., Kleyweg R.P. Guillain-Barré syndrome without sensory loss (acute motor neuropathy): a subgroup with specific clinical, electrodiagnostic and laboratory features. Brain. 118:1995;841-847.
4. Hadden R.D.M., Cornblath D.R., Hughes R.A.C., Zielasek J., Hartung H.-P., Toyka K.V., Swan A.V. Electrophysiological classification of Guillain-Barré syndrome: clinical association and outcome. Ann Neurol. 44:1998;780-788.
5. Chiba A., Kusunoki S., Obata H., Machinami R., Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology. 43:1993;1911-1917.
6. Yuki N. Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody. Ann Neurol. 39:1996;668-672.
7. Mizoguchi K., Hase A., Obi T., Matsuoka H., Takatsu M., Nishimura Y., Irie F., Seyama Y., Hirabayashi Y. Two species of antiganglioside antibodies in a patient with a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 57:1994;1121-1123.
8. Koga M., Yuki N., Ariga T., Morimatsu M., Hirata K. Is IgG anti-GT1a antibody associated with pharyngeal-cervical-brachial weakness or oropharyngeal palsy in Guillain-Barré syndrome? J Neuroimmunol. 86:1998;74-79.
9. Taki T., Hirabayashi Y., Ishikawa H., Ando S., Kon K., Tanaka Y., Matsumoto M. A ganglioside of rat ascites hepatoma AH 7974F cells: occurrence of novel disialoganglioside (GD1α) with a unique N-acetylneuraminosyl(α2-6)-N-acetylgalcosamine structure. J Biol Chem. 261:1986;3075-3078.
10. Taki T., Ogura M., Nakajima M., Handa S. Gangliosides GM1b and GD1α, as the adhesion molecules of mouse lymphosarcoma cells to the hepatic sinusoidal endothelial cells. Glycoconj J. 10:1993;273.
11. Hirabayashi Y., Hyogo A., Nakao T., Tsuchiya K., Suzuki Y., Matsumoto M., Kon K., Ando S. Isolation and characterization of extremely minor gangliosides, GM1b and GD1α, in adult bovine brains as developmentally regulated antigens. J Biol Chem. 265:1990;8144-8151.
12. Ohashi M. A new type of ganglioside: carbohydrate structures of the major gangliosides from frog brain. Yamakawa T., Osawa T., Handa S. Glycoconjugates. 1981;33-34 Japan Scientific Societies Press, Tokyo, Japan.
13. Asbury A.K., Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol. 27:(Suppl):1990;21-24.
14. Koga M, Yuki N, Hirata K. Anti-ganglioside antibody in patients with Guillain-Barré syndrome who show bulbar palsy as an initial symptom. J Neurol Neurosurg Psychiatry (in press).
15. Prabhanjan H., Kiso M., Hasegawa A. Total synthesis of a disialoganglioside GD1α Carbohydr Res. 222:1991;c1-c4.
16. Hotta K., Kawase T., Ishida H., Kiso M., Hasegawa A. Synthetic studies on sialoglycoconjugates 75: a total synthesis of β-series ganglioside GQ1β J Carbohydr Chem. 14:1995;961-975.
17. Hirabayashi Y., Nakao T., Matsumoto M., Obata K., Ando S. Improved method for large-scale purification of brain gangliosides by Q-Sepharose column chromatography: immunochemical detection of C-series polysialogangliosides in adult bovine brains. J Chromatogr. 445:1988;377-384.
18. Yuki N., Taki T., Handa S. Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis. J Neuroimmunol. 71:1996;155-161.
19. Yuki N., Tagawa Y., Irie F., Hirabayashi Y., Handa S. Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1α J Neuroimmunol. 74:1997;30-34.
20. Yoshino H., Miyatani N., Saito M., Ariga T., Lugaresi A., Latov N., Kushi Y., Kasama T., Yu R.K. Isolated bovine spinal motoneurons have specific ganglioside antigens recognized by sera from patients with motor neuron disease and motor neuropathy. J Neurochem. 59:1992;1684-1691.
21. Yoshino H., Maeda Y., King M., Cartwright M.J., Richards D.W., Ariga T., Yu R.K. Sulfated glucuronyl glycolipids and gangliosides in the optic nerve of humans. Neurology. 43:1993;408-411.
22. Hidari K., Kawashima I., Tai T., Inagaki F., Nagai Y., Sanai Y. In vitro synthesis of disialoganglioside (GD1α) from asialo-GM1 using sialyltransferases in rat liver Golgi vesicles. Eur J Biochem. 221:1994;603-609.
23. Odaka M., Yuki N., Yoshino H., Kasama T., Handa S., Irie F., Hirabayashi Y., Suzuki A., Hirata K. N-Glycolylneuraminic acid-containing GM1 is a new molecule for serum antibody in Guillain-Barré syndrome. Ann Neurol. 43:1998;829-834.
24. Latov N., Koski C.L., Walicke P.A. Guillain-Barré syndrome and parenteral gangliosides. Lancet. 338:1991;757.
25. Schönhöfer P.S. Guillain-Barré syndrome and parenteral gangliosides. Lancet. 338:1991;757.
26. Landi G., D'Alessandro R., Dossi B.C., Ricci S., Simone I.L., Ciccone A. Guillain-Barré syndrome after exogenous gangliosides in Italy. Br Med J. 307:1993;1463-1464.
27. Illa I., Ortiz N., Gallard E., Juarez C., Grau J.M., Dalakas M.C. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann Neurol. 38:1995;218-224.
28. Odaka M., Yuki N., Nobile-Orazio E., Carpo M., Hirata K. N-Glycolylneuraminic acid-containing GM1 an immunogen in Guillain-Barré syndrome after ganglioside administration. Muscle Nerve. 7:(Suppl):1998;211.
29. Kusunoki S., Iwamori M., Chiba A., Hitoshi S., Arita M., Kanazawa I. GM1b is a new member of antigen for serum antibody in Guillain-Barré syndrome. Neurology. 47:1996;237-242.
30. Yuki N., Yamada M., Sato S., Ohama E., Kawase Y., Ikuta F., Miyatake T. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome. Muscle Nerve. 16:1993;642-647.
31. Carpo M., Nobile-Orazio E., Meucci N., Gamba M., Barbieri S., Allaria S., Scarlato G. Anti-GD1a ganglioside antibodies in peripheral motor syndromes. Ann Neurol. 39:1996;539-543.
32. Furuya S., Irie F., Hashikawa T., Nakazawa K., Kozakai A., Hasegawa A., Sudo K., Hirabayashi Y. Ganglioside GD1α in cerebellar Purkinje cells. J Biol Chem. 269:1994;32418-32425.
33. Furuya S., Hashikawa T., Hirabayashi Y. Restricted occurrence of an unusual ganglioside GD1α in rat brain and its possible involvement in dendritic growth of cerebellar Purkinje neurons. J Neurosci Res. 44:1996;73-83.